Background: Urosepsis is one of the most common infections that require empirical broad spectrum antibiotics immediately after diagnosis. This has led to development of bacterial resistance by acquiring the capability to destroy the β-lactam ring. Methodology: This is a cross-sectional hospital-based study. The study was conducted from 2019 to 2020 at Gezira Hospital for Renal diseases and surgery (GHRDS). A hundred patients were diagnosed clinically with urosepsis and the isolated organisms were Escherichia coli, Staphylococcus aureus, Proteus mirabilis, Klebsiella pneumonia and Pseudomonas aeruginosa. The susceptibility test was conducted by Kirby Bauer disc diffusion technique according to clinical laboratory standard institute (CLSI) guidelines. Seventy eight samples of bacterial genomic DNA were confirmed by 16srRNA and multiplex PCR, were performed for genotypic blaOXA-51 and blaOXA-23 gene characterization of isolated bacteria. Then gel electrophoresis was used to identify the presence or absence of (blaOXA-51 and blaOXA-23) genes. Results: 88.5% (69/78) in 16srRNA detected. Using multiplex PCR, the frequencies of blaOXA-51 and blaOXA-23 genes were 13% and 10.1%, respectively. The percentages of isolates which yielded both blaOXA-51 and blaOXA-23 among P. aeruginosa was 25% (1/4), among K. pneumonia was 17% (1/6), and among E. coli was 8% (3/37). Only blaOXA-51 was detected in P. mirabilis 10% (1/10) and only blaOXA-23 was detected in S. aureus 5% (1/18). Conclusion: In this study, the presence of blaOXA-51 and blaOXA-23 genes was increased in the isolated bacteria.
References
[1]
Wang, S., Yuan, P., Peng, E., Xia, D., Xu, H., Wang, S., et al. (2020) Risk Factors for Urosepsis after Minimally Invasive Percutaneous Nephrolithotomy in Patients with Preoperative Urinary Tract Infection. BioMed Research International, 2020, Article ID: 1354672. https://doi.org/10.1155/2020/1354672
[2]
Ryan, J., O’Neill, E. and McLornan, L. (2021) Urosepsis and the Urologist! Current Urology, 15, 39-44. https://doi.org/10.1097/CU9.0000000000000006
[3]
Porat, A., Bhutta, B.S. and Kesler, S. (2022) Urosepsis. In: StatPearls [Internet], StatPearls Publishing, Treasure Island.
http://www.ncbi.nlm.nih.gov/books/NBK482344/
[4]
Bonkat, G., Cai, T., Veeratterapillay, R., Bruyère, F., Bartoletti, R., Pilatz, A., et al. (2019) Management of Urosepsis in 2018. European Urology Focus, 5, 5-9.
https://doi.org/10.1016/j.euf.2018.11.003
[5]
Scotland, K. and Lange, D. (2018) Prevention and Management of Urosepsis Triggered by Ureteroscopy. Research and Reports in Urology, 10, 43-49.
https://doi.org/10.2147/RRU.S128071
[6]
World Health Organization (2017, February 27) WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed.
https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
[7]
Rodriguez, M. (2020, August 19) Whole Genome Analysis of Two Multiresistant Escherichia coli Strains. Effect of Grape Polyphenols on Bacterial Growth. Enoforum.
https://www.enoforum.eu/en/poster2020/viticast-production-optimization-and-sustainable-development-of-the-vine-cultivation-through-fungal-diseases-prediction-feuga-viticast/
[8]
Jesumirhewe, C., Springer, B., Allerberger, F. and Ruppitsch, W. (2020) Whole Genome Sequencing of Extended-Spectrum β-Lactamase Genes in Enterobacteriaceae Isolates from Nigeria. PLoS ONE, 15, Article ID: e0231146.
https://doi.org/10.1371/journal.pone.0231146
[9]
Ur Rahman, S., Ali, T., Ali, I., Khan, N.A., Han, B. and Gao, J. (2018) The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases. BioMed Research International, 2018, Article ID: 9519718.
https://doi.org/10.1155/2018/9519718
[10]
Zango, U.U., Ibrahim, M., Shawai, S.A.A. and Shamsuddin, I.M. (2019) A Review on β-Lactam Antibiotic Drug Resistance. Drug Design, Development and Therapy, 3, 52-58.
[11]
Tshitshi, L., Manganyi, M.C., Montso, P.K., Mbewe, M. and Ateba, C.N. (2020) Extended Spectrum Beta-Lactamase-Resistant Determinants among Carbapenem-Resistant Enterobacteriaceae from Beef Cattle in the North West Province, South Africa: A Critical Assessment of Their Possible Public Health Implications. Antibiotics, 9, Article No. 820. https://doi.org/10.3390/antibiotics9110820
[12]
Codjoe, F.S. and Donkor, E.S. (2017) Carbapenem Resistance: A Review. Medical Sciences, 6, Article No. 1. https://doi.org/10.3390/medsci6010001
[13]
Dahab, R.A., Ibrahim, A.M. and Altayb, H.N. (2017) Phenotypic and Genotypic Detection of Carbapenemase Enzymes Producing Gram-Negative Bacilli Isolated from Patients in Khartoum State. F1000Research, 6, Article No. 1656.
https://doi.org/10.12688/f1000research.12432.1
[14]
Smith, H.Z and Kendall, B. (2022) Carbapenem Resistant Enterobacteriaceae. In: StatPearls, StatPearls Publishing, Treasure Island.
http://www.ncbi.nlm.nih.gov/books/NBK551704/
[15]
Hansen, G.T. (2021) Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance among Enterobacterales and Other Gram-Negative Bacteria. Infectious Diseases and Therapy, 10, 75-92.
https://doi.org/10.1007/s40121-020-00395-2
[16]
Poirel, L., Naas, T. and Nordmann, P. (2010) Diversity, Epidemiology, and Genetics of Class D β-Lactamases. Antimicrobial Agents and Chemotherap, 54, 24-38.
https://doi.org/10.1128/AAC.01512-08
[17]
Wong, M.H., Chan, B.K., Chan, E.W. and Chen, S. (2019) Over-Expression of ISAba1-Linked Intrinsic and Exogenously Acquired OXA Type Carbapenem-Hydrolyzing-Class D-β-Lactamase-Encoding Genes Is Key Mechanism Underlying Carbapenem Resistance in Acinetobacter baumannii. Frontiers in Microbiology, 10, Article No. 2809.
https://doi.org/10.3389/fmicb.2019.02809
https://www.frontiersin.org/article/10.3389/fmicb.2019.02809
[18]
Mana, H.A., Sundararaju, S., Tsui, C.K.M., Perez-Lopez, A., Yassine, H., Thani, A.A., et al. (2021) Whole-Genome Sequencing for Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae Causing Lower Urinary Tract Infection among Pediatric Patients. Antibiotics, 10, Article No. 972.
https://doi.org/10.3390/antibiotics10080972
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388976/
[19]
Nordmann, P. and Poirel, L. (2019) Epidemiology and Diagnostics of Carbapenem Resistance in Gram-Negative Bacteria. Clinical Infectious Diseases, 69, S521-S528.
https://doi.org/10.1093/cid/ciz824
Queenan, A.M. and Bush, K. (2007) Carbapenemases: The Versatile β-Lactamases. OXA β-Lactamases. Clinical Microbiology Reviews, 27, 241-263., 20, 440-458.
https://doi.org/10.1128/CMR.00001-07
[22]
Segagni Lusignani, L., Presterl, E., Zatorska, B., Van den Nest, M. and Diab-Elschahawi, M. (2020) Infection Control and Risk Factors for Acquisition of Carbapenemase-Producing Enterobacteriaceae. A 5 Year (2011-2016) Case-Control Study. Antimicrobial Resistance & Infection Control, 9, Article No. 18.
https://doi.org/10.1186/s13756-019-0668-2
[23]
Zahedi bialvaei, A., Samadi kafil, H., Ebrahimzadeh Leylabadlo, H., Asgharzadeh, M. and Aghazadeh, M. (2015) Dissemination of Carbapenemases Producing Gram Negative Bacteria in the Middle East. Iranian Journal of Microbiology, 7, 226-246.
[24]
Tsilipounidaki, K., Athanasakopoulou, Z., Müller, E., Burgold-Voigt, S., Florou, Z., Braun, S.D., et al. (2022) Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution. Microorganisms, 10, Article No. 159.
https://doi.org/10.3390/microorganisms10010159
[25]
Brink, A.J. (2019) Epidemiology of Carbapenem-Resistant Gram-Negative Infections Globally. Current Opinion in Infectious Diseases, 32, 609-616.
https://doi.org/10.1097/QCO.0000000000000608
[26]
Ibrahim, M.E., Bilal, N.E., Magzoub, M.A. and Hamid, M.E. (2013) Prevalence of Extended-Spectrum β-Lactamases-Producing Escherichia coli from Hospitals in Khartoum State, Sudan. Oman Medical Journal, 28, 116-120.
https://doi.org/10.5001/omj.2013.30
[27]
Mohamed Elmutasim, A.M., Abdalla, O.A., El-Shiekh, B.K., Bashir, S. and Musa, A.A. (2019) Phenotypic and Genotypic Characterization of Carbapenemsresistant clinical Gram-Negative Bacteria from Sudan. Edorium Journal of Microbiology, 5, Article ID: 100011M08MM2019.
http://edoriumjournalofmicrobiology.com/archive/article-full-text/100011M08MM2019
[28]
Chen, Y.-L., Lee, C.-C., Lin, Y.-L., Yin, K.-M., Ho, C.-L. and Liu, T. (2015) Obtaining Long 16S rDNA Sequences Using Multiple Primers and Its Application on Dioxin-Containing Samples. BMC Bioinformatics, 16, Article No. S13.
https://doi.org/10.1186/1471-2105-16-S18-S13
[29]
Joshi, P.R., Acharya, M., Kakshapati, T., Leungtongkam, U., Thummeepak, R. and Sitthisak, S. (2017) Co-Existence of blaOXA-23 and blaNDM-1 Genes of Acinetobacter baumannii Isolated from Nepal: Antimicrobial Resistance and Clinical Significance. Antimicrobial Resistance & Infection Control, 6, Article No. 21.
https://doi.org/10.1186/s13756-017-0180-5
[30]
Bhojani, N., Miller, L.E., Bhattacharyya, S., Cutone, B. and Chew, B.H. (2021) Risk Factors for Urosepsis After Ureteroscopy for Stone Disease: A Systematic Review with Meta-Analysis. Journal of Endourology, 35, 991-1000.
https://doi.org/10.1089/end.2020.1133
[31]
Ibrahim, S.O., Elimam, M., Taha, S.M., Yousif, S.M., Omer, H.M.H., Yousif, M., et al. (2022) Urosepsis among Sudanese Patients: A Paradigm from Limited Resources Country. Advances in Microbiology, 12, 109-120.
https://doi.org/10.4236/aim.2022.123010
[32]
Goveas, B. (2017) Urosepsis: A Simple Infection Turns Toxic. The Nurse Practitioner, 42, 53-54. https://doi.org/10.1097/01.NPR.0000520425.91534.b8
[33]
Muhammad, A.S., Onwuasoanya, U.E., Mohammad, Y., Agwu, N.P., Abdulwahab-Ahmed, A. and Mungadi, I.A. (2021) Presentation, Risk Factors, Microbiological Pattern and Management of Urosepsis in a Tertiary Hospital in Nigeria. Basic Research Journal of Medicine and Clinical Sciences, 1, 1-7.
[34]
Mouiche, M.M.M., Moffo, F., Akoachere, J.-F.T.K., Okah-Nnane, N.H., Mapiefou, N.P., Ndze, V.N., et al. (2019) Antimicrobial Resistance from a One Health Perspective in Cameroon: A Systematic Review and Meta-Analysis. BMC Public Health, 19, Article No. 1135. https://doi.org/10.1186/s12889-019-7450-5
[35]
Moglad, E.H. (2020) Antibiotics Profile, Prevalence of Extended-Spectrum Beta-Lactamase (ESBL), and Multidrug-Resistant Enterobacteriaceae from Different Clinical Samples in Khartoum State, Sudan. International Journal of Microbiology, 2020, Article ID: 8898430. https://doi.org/10.1155/2020/8898430
[36]
Wagenlehner, F.M.E., Bjerklund Johansen, T.E., Cai, T., Koves, B., Kranz, J., Pilatz, A., et al. (2020) Epidemiology, Definition and Treatment of Complicated Urinary Tract Infections. Nature Reviews Urology 17, 586-600.
https://doi.org/10.1038/s41585-020-0362-4
[37]
Ladjevic, N., Vuksanovic, A., Durutovic, O., Jovicic, J., Ladjevic, N., Likic-Ladjevic, I., et al. (2021) Urosepsis in Adults. Archives of Biological Sciences, 73, 205-214.
https://doi.org/10.2298/ABS210304015L
[38]
Abdelaziz, N.A. (2022) Phenotype-Genotype Correlations among Carbapenem-Resistant Enterobacterales Recovered from Four Egyptian Hospitals with the Report of SPM Carbapenemase. Antimicrobial Resistance & Infection Control, 11, Article No. 13. https://doi.org/10.1186/s13756-022-01061-7
